Skip to main content
logo
GenFleet Therapeutics (Shanghai) Inc. (HKG:2595)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
38.36
+2.36 (6.56%)
Jul 10, 2026, 4:08 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Biopharmaceutical Research and Development
130.27M104.70M73.73M
Biopharmaceutical Research and Development Growth
24.42%42.00%-
Total
130.27M104.70M73.73M
Total Growth
24.42%42.00%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
United States
130.27M104.70M-
United States Growth
24.42%--
Chinese Mainland
--71.78M
Overseas
--1.96M
Total
130.27M104.70M73.73M
Total Growth
24.42%42.00%-